Genetic Analysis’ CTO finalist in the Lyfebulb and Bristol Myers Squibb Innovation Challenge addressing unmet needs in IBD 2023-02-022023-01-27
Genetic Analysis AS achieves Thai FDA License for GA-map® Dysbiosis Test in Thailand 2023-01-262023-01-19
Genetic Analysis AS enters an agreement with Microbiome Research Pvt. Ltd. to launch GA-map® technology in India 2023-01-262023-01-16
Genetic Analysis AS enters an agreement with Hausen Bernstein Co. Ltd. to launch GA-map® technology in Thailand 2023-01-262022-11-30
Genetic Analysis AS enters an agreement with a major diagnostic company for distribution of GA-map® in Europe 2022-11-152022-11-07
Genetic Analysis appoints Sedermera Corporate Finance AB to act as a liquidity provider for the Company´s share 2022-09-012022-09-01
Eilert Aamodt 
